LAVA Therapeutics
LVTX
LVTX
19 hedge funds and large institutions have $6.77M invested in LAVA Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
4
Closed
3
Calls
$174K
Puts
$66K
Net Calls
+$108K
Net Calls Change
+$209K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$119K |
| 2 |
PFA
Pathway Financial Advisors
South Burlington,
Vermont
|
+$82.8K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$55.5K |
| 4 |
Two Sigma Investments
New York
|
+$54.7K |
| 5 |
Two Sigma Advisers
New York
|
+$27K |
Top Sellers
| 1 |
Walleye Capital
New York
|
-$232K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$60.9K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$43K |
| 4 |
AWG
Alpha Wave Global
New York
|
-$36.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$29.9K |
